Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Observation × Other solid neoplasm × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Gastrointestinal 24 Gynecologic 14 Thoracic 13 Genitourinary 13 Lymphoid 9 Head & Neck 9 CNS 9 Breast 9 Other hematologic neoplasm 8 Dermatologic 6 Plasma cell 5 Myeloid 3 Tumor-Agnostic 2 Sarcoma 2 Endocrine 2 Classical hematology 2 Other solid neoplasm 1 Other neoplasm 1 Other 1

Conditions

Retinoblastoma 1

Interventions

Cisplatin 129 pembrolizumab 106 Carboplatin 104 Paclitaxel 87 Injections 86 Pemetrexed 81 Gemcitabine 73 Irinotecan 64 Cyclophosphamide 61 Docetaxel 58 Nivolumab 57 Bevacizumab 53 Fluorouracil 44 Capecitabine 42 Oxaliplatin 41 atezolizumab 39 Leucovorin 38 tislelizumab 36 Etoposide 34 toripalimab 28 fludarabine 27 Ipilimumab 27 Topotecan 24 Radiotherapy 24 durvalumab 23 Drug Therapy 23 olaparib 21 Vincristine 21 Sorafenib 21 spartalizumab 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02870907 2026-01-07

RB SFCE 09

Institut Curie

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡